Tenet Healthcare (THC) PT Raised to $40 at Leerink Partners
Leerink Partners raised its price target on Tenet Healthcare (NYSE: THC) to $40.00 (from $30.00) while maintaining a Outperform rating.
Leerink Partners raised its price target on Tenet Healthcare (NYSE: THC) to $40.00 (from $30.00) while maintaining a Outperform rating.